Search results

• Croda supports Pfizer-BioNTech COVID-19 vaccine

  Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.

• Investing in organic expansion in Agriculture

  Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.

• Symiro™ biostimulant

  As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.

• Ratings and frameworks

  View our ratings and frameworks which help to shape our sustainability programme.

• Share price

  Detailed share charts.

• Procurement and sustainable sourcing

  Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.

• Croda acquires Inventiva, encapsulation and delivery system technology

  It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.

• Croda acquires research enterprise Enza Biotech

  Developing the next generation of renewable surfactants using carbohydrate-based chemistry.

• Croda expands Iberchems fragrances offering with the acquisition of Parfex

  Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares, comprising the founding shareholders and certain minority investors.

• Acquisition of Alban Muller

  The acquisition expands Croda’s portfolio of sustainable active ingredients for customers in personal care markets.

• Our sustainability leadership

  Discover how Croda are driving deeper impact to create greater value across fewer targets.

• Our Commitment

  Croda is committed to being Climate, Nature, and People Positive by 2030, integrating sustainability into its core practices to positively impact the environment and society for a healthier planet and future generations.

• Our Fundamentals

  We will consider all stakeholders in our ecosystem and adopt best practices in environment, labour and human rights, ethics and sustainable procurement.

• Nature Positive

  By 2030, we will be Nature Positive.

• Ethics

  Responsible and ethical behaviour is fundamental to the way we operate at Croda.

• Investor overview

  Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

• Sustainability

  Sustainability spans every area of our business and is a crucial way we add value to our customers.

• Life Sciences sustainability review

  Sustainability is embedded in our business strategy, shaping innovation and meeting customer expectations. In Life Sciences, it drives impact, performance and long-term value.

• Chief Executive sustainability statement

  “By thinking boldly, acting with purpose, and living our values every day, we are bringing Smart science to improve lives™ to life and working hard to achieve our commitment to be the most sustainable supplier of innovative ingredients by 2030, delivering solutions to tackle some of the world’s biggest challenges”

• Why invest in Croda?

  Discover why investing in Croda offers long-term growth, innovation-led performance, and sustainable value across global specialty chemicals markets.

• 2025 Annual Report

  Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.

• Chairs statement 2025

  A message from the Chair, Danuta Gray, highlighting the company’s performance, strategic progress, governance priorities, and outlook for sustainable growth in the year ahead.

• Chief Executive's Statement 2025

  An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Behind the Science

  Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

• Meet the expert: Dhanila Varkey, Applications Team Lead

  Discover how Croda’s applications expert Dhanila Varkey is using nanotechnology to improve targeting, absorption and effectiveness in topical and transdermal drug delivery.

• Meet the expert: Will Small, Research & Technology Specialist

  Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

• Meet the expert: Chris Wells, Applications Team Lead

  Meet the expert: Chris Wells, Applications Team Lead

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Croda Foundation

  Introduction to the Croda Foundation, the independently managed, philanthropic arm of Croda International.

• Greater China

  Croda has been present in China since 1993.

• Leadership

  Our Board and Executive Committee provide leadership in delivering for our customers and achieving our strategic priorities.

• Current vacancies

  At Croda, our people are our difference. We are committed to using Smart science to improve lives™ while driving a sustainable future. Join our team and be part of a responsible, inclusive culture where your contributions make an impact.

• Bank of America Beauty Event

  16 May 2025: Croda International plc hosted a Croda Beauty Event with Bank of America.

• Site visit to Incotec Seed Treatment business in the Netherlands

  11 April 2018: Croda International plc hosted an investor event for analysts and investors on 11 April 2018 at its Incotec facility in the Netherlands and concluded on 12 April 2018 with a series of presentations in Amsterdam.

• Jefferies visit to Grasse May 2025

  22 May 2025: Croda International plc hosted Jefferies at a tour of our F&F site, Parfex in Grasse, France.

• Our Values

  At Croda, our company core values of Responsible, Innovative, and Together are at the heart of how we operate, shaping a unique, collaborative culture that supports our Purpose.

• Sustainability Report archive

  View our sustainability report archives.

• Croda announces brand evolution to mark centenary year animation Page Summary Title

  Croda announces brand evolution to mark centenary year animation Page Summary Description

• Launching futures

  Embarking on excellence with our transformative graduate scheme

• Global Graduate Development Programme Opportunities

  Our programme for recent graduates offers a unique experience. All schemes enable you to quickly grow an understanding of the business and the different areas within.